Rivastigmine for Alzheimer's disease (French version)

Cochrane Missing Files: Clear cache (in 'Performance') in order to make the error page work!

Cochrane Missing Files: Clear cache (in 'Performance') in order to make the access denied page work!

Warning: Parameter 2 to onepixelout_swftools_flashvars() expected to be a reference, value given in module_invoke() (line 476 of /var/www/community.cochrane.org/includes/module.inc).

To browse Podcasts by topic, please visit the new Cochrane Summaries site here

The use of cholinesterase inhibitors in people with Alzheimer's disease has long been a focus of interest and concern. In this podcast, Jacqueline Birks, a researcher from Oxford, England, reports the results of an updated systematic review studying the benefits and harms of one of these agents, rivastigmine, including a novel mode of percutaneous administration. (French version)